Cargando…

The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field

Leukotrienes (LTs) are potent biological proinflammatory mediators. LTC4, LTD4, and LTE4 are more frequently involved in chronic inflammatory responses and exert their actions binding to a cysteinyl-LT 1 (CysLT1) receptor and a cysteinyl-LT 2 (CysLT2) receptor. LTs receptor antagonists available for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nettis, Eustachio, D'Erasmo, Maddalena, Di Leo, Elisabetta, Calogiuri, Gianfranco, Montinaro, Vincenzo, Ferrannini, Antonio, Vacca, Angelo
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945673/ https://www.ncbi.nlm.nih.gov/pubmed/20886028 http://dx.doi.org/10.1155/2010/628171

Ejemplares similares

Oral Allergy Syndrome in a Child Provoked by Royal Jelly
por: Paola, Fantini, et al.
Publicado: (2014)

Hypersensitivity reactions due to black henna tattoos and their components: are the clinical pictures related to the immune pathomechanism?
por: Calogiuri, Gianfranco, et al.
Publicado: (2017)

Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
por: Nettis, E, et al.
Publicado: (2008)

Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology
por: Nettis, Eustachio, et al.
Publicado: (2020)

Focus on the role of substance P in chronic urticaria
por: Vena, Gino A., et al.
Publicado: (2018)

Leukotriene Antagonists in Dermatology
por: Bubna, Aditya Kumar
Publicado: (2021)

Unmet diagnostic needs in contact oral mucosal allergies
por: Minciullo, Paola Lucia, et al.
Publicado: (2016)

Molecular allergology
por: Bernardini, Roberto, et al.
Publicado: (2014)

Update on leukotriene receptor antagonists in preschool children wheezing disorders
por: Montella, Silvia, et al.
Publicado: (2012)

The roadmap for allergology in Europe: The European training requirements for the specialty of allergology
por: Gerth van Wijk, Roy, et al.
Publicado: (2020)

ALLERGOLOGY: Proceedings of the Fourth International Congress of Allergology, New York, 1961
Publicado: (1963)

Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
por: Fiorino, Irene, et al.
Publicado: (2014)

The astrolabe of molecular allergology
por: Belaid, Djoumouai
Publicado: (2014)

Allergic contact dermatitis from vitamins: A systematic review
por: Foti, Caterina, et al.
Publicado: (2022)

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
por: Noronha, Letícia Paula Trajano, et al.
Publicado: (2023)

Churg-Strauss syndrome associated with leukotriene receptor antagonists.
por: McAuley, D. F., et al.
Publicado: (2001)

Side effects of the leukotriene receptor antagonists in asthmatic children
por: Can, Demet, et al.
Publicado: (2015)

Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children
por: Erdem, Semiha Bahceci, et al.
Publicado: (2015)

The paucity of ethical analysis in allergology
por: Behrmann, Jason
Publicado: (2013)

Leukotriene receptor antagonists for chronic urticaria: a systematic review
por: de Silva, Nipun Lakshitha, et al.
Publicado: (2014)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010)

Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
por: Kemp, James P
Publicado: (2009)

Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics
por: Park, Jong Sook, et al.
Publicado: (2010)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
por: Aigner, Ludwig, et al.
Publicado: (2020)

Leukotriene Antagonist Use is Associated With Lower Systolic Blood Pressure in Adults
por: Lai, Jennifer, et al.
Publicado: (2022)

Nonsteroidal Topical Immunomodulators in Allergology and Dermatology
por: Jovanović, Marina, et al.
Publicado: (2016)

Advances and novel developments in molecular allergology
por: Üzülmez, Öykü, et al.
Publicado: (2020)

Editorial: Insights in allergology: 2021/22
por: Gadermaier, Gabriele, et al.
Publicado: (2023)

Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)

Focus on the agents most frequently responsible for perioperative anaphylaxis
por: Di Leo, E., et al.
Publicado: (2018)

Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010)

Involvement of new oxidative stress markers in chronic spontaneous urticaria
por: Nettis, Eustachio, et al.
Publicado: (2017)

The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?
por: McDanel, Deanna L, et al.
Publicado: (2005)

Role of Leukotriene Receptor Antagonists in the Treatment of Exercise-Induced Bronchoconstriction: A Review
por: Philteos, George S, et al.
Publicado: (2005)

Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
por: Theron, A. J., et al.
Publicado: (2014)

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

Is Leukotriene Receptor Antagonist the Direct Cause of Churg-Strauss Syndrome in Asthmatic Patients?
por: Paul, Salomi, et al.
Publicado: (2022)

Use of Leukotriene-Receptor Antagonists During Pregnancy and Risk of Neuropsychiatric Events in Offspring
por: Tsai, Hui-Ju, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6f6ddqnrgka0eisgih3fslab6a